Physician profile
Moses Braimoh
NPI 1467984146
$4,216.37
in general payments reported to CMS, 2019-2025
15 companies · $2,723 in 2025
The $2,723 reported for 2025 was more than what 88% of Public Health & General Preventive Medicine providers received nationally (typical 2025 total: $95.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $237 · 2024: $1,256 · 2025: $2,723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,216.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,523.86 | 2023-2025 | Cabenuva, Apretude, Dovato |
| Gilead Sciences, INC. | $1,118.03 | 2024-2025 | Yeztugo, Epclusa |
| Merck Sharp & Dohme LLC | $336.65 | 2023-2025 | Pifeltro, Delstrigo |
| Braeburn INC. | $258.45 | 2024-2025 | Brixadi |
| Alkermes, INC. | $255.32 | 2023-2025 | Vivitrol, Aristada, Lybalvi |
| Theratechnologies INC. | $225.34 | 2025 | Egrifta, Trogarzo |
| Otsuka America Pharmaceutical, INC. | $133.38 | 2024-2025 | Abilify Asimtufii, Abilify Maintena |
| Novo Nordisk INC | $105.01 | 2023 | Wegovy |
| Emd Serono, INC. | $79.09 | 2024-2025 | |
| Axsome Therapeutics, INC. | $66.66 | 2025 | Auvelity |
| Abbvie INC. | $40.40 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.85 | 2025 | Caplyta |
| Exact Sciences Corporation | $21.37 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $14.12 | 2025 | Invega Trinza, Invega Sustenna |
| Indivior INC. | $13.84 | 2025 | Sublocade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moses Braimoh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.